Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-057650)

Filing Details

Accession Number:: 0001209191-23-057650
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-06 17:16:48
Reporting Period:: 2023-12-05

Accepted Time:: 2023-12-06 17:16:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759425	Mirum Pharmaceuticals Inc.	MIRM	Pharmaceutical Preparations (2834)	831281555

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1974200	Jolanda Howe	C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404	Svp, Global Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-12-05	2,500	$2.94	2,500	No	4	M	Direct
Common Stock	Disposition	2023-12-05	2,500	$32.40	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2023-12-05	2,500	$0.00	2,500	$2.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
55,400		2029-03-11	No	4	M	Direct

Footnotes

1/4th of the 62,500 shares originally subject to the option vested one year after February 28, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments at the end of each month thereafter.